Dr. Dipen Maru, MD

• Anatomic & Clinical Pathology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Tex Md Anderson Cancer Center

  Fellowship Hospital, 2003

• University Hospital

  Residency Hospital, 2002

• Hahnemann University Hospital

  Fellowship Hospital, 1998

• Mp Shah Med Coll, Jamnagar

  Medical School, 1989

• Mp Shah Medical College

  Internship Hospital, 1989

• RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases, 2013-11-05

• Early metabolic change after induction chemotherapy predicts histologic response and prognosis in patients with esophageal cancer: Secondary analysis of a randomized trial, 2017-12-09

• Multicenter Validation Study of Pathologic Response and Tumor Thickness at the Tumor-Normal Liver Interface as Independent Predictors of Disease-Free Survival after Preoperative Chemotherapy and Surgery for Colorectal Liver Metastases, 2013-04-23

• Genomic analysis of exceptional responder to regorafenib in treatment-refractory metastatic rectal cancer: a case report and review of the literature, 2017-06-03

• Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma, 2017-05-23

• Exploratory study of macrophage polarization and spatial distribution in colorectal cancer liver metastasis: a pilot study, 2023-08-10

• Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting, 2020-10-27

• Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma, 2018-03-22

• RASmutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases, 2014-09-17

• Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study, 2016-03-11

• Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype Through a Soluble Form of Jagged-1, 2013-01-31

• Number of Lymph Nodes Examined and Prognosis Among Pathologically Lymph Node-Negative Patients After Preoperative Chemoradiation Therapy for Rectal Adenocarcinoma, 2011-02-15

• Loss of TGF-ß Adaptor ß2SP Activates Notch Signaling and SOX9 Expression in Esophageal Adenocarcinoma, 2013-03-27

• Geographic Distribution of Regional Metastatic Nodes Affects Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma, 2015-02-28

• Preoperative Radiation Therapy with Concurrent Capecitabine, Bevacizumab and Erlotinib for Rectal Cancer: A Phase I Trial, 2013-12-05

• KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer, 2019-03-21

• TP53 loss creates therapeutic vulnerability in colorectal cancer, 2015-04-22

• Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases, 2013-11-25

• Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases, 2021-04-02

• ARID1A mutation may define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer, 2021-01-07

• Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation, 2012-09-04

• Brain metastasis in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastasis, 2020-04-28

• Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab, 2017-10-30

• Fecal Microbiota Transplantation for refractory immune checkpoint inhibitor-associated colitis, 2018-11-12

• Gadolinium Chloride Augments Tumor-Specific Imaging of Targeted Quantum Dotsin vivo, 2010-07-27

• Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer, 2017-03-07

• Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma, 2021-07-14

• Margin Status Remains an Important Determinant of Survival after Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy, 2013-03-29

• Barrett's Esophagus After Bimodality Therapy in Patients With Esophageal Adenocarcinoma, 2018-05-29

• Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC, 2019-11-28

• RASmutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases, 2016-03-25

• Residual Tumor Thickness at the Tumor-Normal Tissue Interface Predicts the Recurrence-free Survival in Patients with Liver Metastasis of Breast Cancer, 2014-07-17

• Is Resection of Colorectal Liver Metastases after a Second-Line Chemotherapy Regimen Justified?, 2011-03-28

• Dysfunctional TGF-ß signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma, 2011-02-08